A3 adenosine receptor agonist prevents the development of paclitaxel-induced neuropathic pain by modulating spinal glial-restricted redox-dependent signaling pathways. (Q35928226)
Jump to navigation
Jump to search
scientific article published on 19 September 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A3 adenosine receptor agonist prevents the development of paclitaxel-induced neuropathic pain by modulating spinal glial-restricted redox-dependent signaling pathways. |
scientific article published on 19 September 2014 |
Statements
A3 adenosine receptor agonist prevents the development of paclitaxel-induced neuropathic pain by modulating spinal glial-restricted redox-dependent signaling pathways (English)
Emanuela Esposito
Daniela Salvemini
Kali Janes
Dillip K Tosh
19 September 2014
1 reference
1 reference
1 reference
1 reference